PointClickCare
Software that nursing homes and post-acute care facilities use to run billing, charting, and care records.
On the record
Checkpoint: Confirmation of size and timing of announced dividend recapitalization
The call
PointClickCare's grip on nursing home billing and records keeps it hard to replace, though a debt-funded dividend payout could squeeze future product spending.
PointClickCare makes the main computer system that nursing homes use to manage patients, billing, and regulations. It is hard to replace because nursing homes are small and spread out (not like big hospitals), so Epic and Meditech ignore them, and anyone starting fresh would need years of nursing home data and government billing knowledge to catch up. The one thing to watch is whether AI tools that handle paperwork and patient intake faster (like Enzo Health) grow fast enough to break into nursing homes, or whether PointClickCare's own new AI features (like Advisor Suite) keep it ahead.
Why
01
AI pressure: Enzo Health and other AI-native documentation/intake startups. AI startups can automate intake and notes but lack CMS billing ties and 30,000 facility relationships PointClickCare already has. Could AI do the core job? Unlikely.
02
Bigger players: Epic Systems and Meditech. Both could build long-term care software but their business model runs on big hospital systems, not thousands of small nursing homes. Could a giant copy it? No, they are blocked.
03
What protects it. It holds the billing and clinical records for about 70% of US nursing homes, and switching means redoing Medicare billing workflows.
What would change this call
PitchBook's announced dividend recapitalization is confirmed with disclosed size and terms. Shows how much debt is added and whether PE ownership is extracting cash from the business.
MatrixCare (ResMed) launches an AI feature suite comparable to Advisor Suite or Discharge Intel. Shows the closest incumbent peer closing the AI feature gap in LTPAC.
Any SNF chain publicly switches from PointClickCare to a rival like WellSky, Netsmart, or an AI-native challenger. Would be the first visible sign of real customer loss despite PointClickCare's high retention.
MatrixCare (ResMed) launches an AI feature suite comparable to Advisor Suite or Discharge Intel. Shows the closest incumbent peer closing the AI feature gap in LTPAC.
Any SNF chain publicly switches from PointClickCare to a rival like WellSky, Netsmart, or an AI-native challenger. Would be the first visible sign of real customer loss despite PointClickCare's high retention.
Key numbers
- ~70% of US nursing homes run on this system
- 30,000+ provider organizations use the platform
- Valuation topped $5 billion
Named risks
- Unconfirmed dividend recapitalization could increase leverage and pressure R&D or product cadence.
- AI-native documentation challengers eroding specific workflow niches like chart review and intake.
- Financial and market share figures rely heavily on vendor-adjacent or aggregator sources rather than audited disclosures.
- Possible cross-setting entry by Epic or Meditech if care delivery converges across acute and long-term settings.
- Headcount contraction of 2.6% in 2025 could signal cost pressure ahead of a private equity ownership transition.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| MatrixCare (ResMed) | contesting | Named main multi-setting LTPAC rival in post-acute suites, per Feb 2026 comparison |
| WellSky | contesting | Broad post-acute and home health suite with analytics, cited June 2026 |
| Netsmart (myUnity) | contesting | Cross-setting EHR strong in hospice, cited June 2026 |
| Epic and Meditech | gaining on | Structurally blocked from fragmented SNF market by hospital-focused business model, no rival product shipped as of July 2026 |
| Enzo Health and AI-native documentation challengers | losing to | Feature-level threat on documentation and intake speed; PointClickCare responded with Advisor Suite, June 2026 |
Questions people ask
- Is PointClickCare profitable in 2026?
- PointClickCare does not disclose audited profitability figures. Executive Chair Mike Wessinger stated in 2022 that revenue exceeded US$500M with about 20% annual growth. Later 2026 estimates from ZoomInfo also cite roughly $500M revenue, but no profit or margin figures have been publicly confirmed as of July 2026.
- Who owns PointClickCare?
- PointClickCare is privately held. Hellman & Friedman became a strategic investor in January 2021 alongside existing backer Dragoneer Investment Group, valuing the company near $4B. In July 2022, H&F and JMI Equity bought additional secondary shares, pushing valuation above US$5B per Globe and Mail reporting.
- Could AI replace PointClickCare?
- Unlikely soon. PointClickCare holds an entrenched system of record across long term care with claimed 30,000plus provider customers as of April 2026 and CMS billing lock in. Rather than being displaced, it is absorbing AI itself, launching Advisor Suite and Discharge Intel in 2026 to automate documentation and billing tasks internally.
- Is PointClickCare laying off employees?
- Headcount data is mixed. Revelio Labs reported about 2,670 employees in December 2025, down 2.6% from 2,740 in 2024, suggesting modest contraction rather than major layoffs. PitchBook separately lists 2,310 employees for 2025, so exact trend is unconfirmed.
- Who is PointClickCare's biggest competitor?
- MatrixCare, owned by ResMed since 2018, is described as PointClickCare's main multi-setting rival in long term and post-acute care software, per a February 2026 comparison from tadabase.io. WellSky and Netsmart are also cited as broad post-acute competitors.
- Is PointClickCare a safe company to join in 2026?
- PointClickCare shows steady product investment, shipping four AI features between March and June 2026 including Discharge Intel and Advisor Suite. However, PitchBook's 2026 profile flags an announced dividend recapitalization, unconfirmed by independent press, which could affect future leverage and hiring.
Timeline
- 2026-06-08Introduced PAC Management IQ, AI discharge planning tool, at AHIP 2026
- 2026-06-02Launched Advisor Suite with new Billing Advisor for pre-claim revenue capture
- 2026-05-12Expanded Chart Advisor AI tool from skilled nursing into senior living
- 2026-05-07Awarded Best EHR Solution at 2026 MedTech Breakthrough Awards
- 2026-04-09Launched Study Buddy, AI powered LTC research platform
- 2026-03-04Launched Discharge Intel AI tool at HIMSS26
- 2025-10-16Unveiled new brand identity and AI innovations at HLTH 2025
- 2022-07-11H&F and JMI Equity secondary purchase pushed valuation above US$5B
- 2021-01-06Hellman & Friedman entered as investor, valuing company near $4B
- 2018-02-28Dragoneer purchased additional US$146M in secondary shares
Revision history
22 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Products, Competitors, Financials... (2026-07-02)
- PointClickCare Company Profile
- PointClickCare press release (2025-06-14 (republished))
- Dragoneer acquires US$146M PointClickCare shares (2018-02-28)
- PointClickCare Technologies Enters Next Phase of Growth (2021-01-06)
- PointClickCare valuation tops US$5-billion (2022-07-11)
- The Full List of 5 Elder Care Unicorn Startups (2025-12-04)
- PointClickCare 2026 Company Profile
- PointClickCare - Overview, News & Similar companies (2026-06-24)
- PointClickCare's value rises to $5bn
- PointClickCare Launches Study Buddy (2026-04-09)
- Hellman & Friedman (2025-11-18 (republished))